Are Opioid Risk Evaluation and Mitigation Strategies (REMS) Interrupting Your Sleep?

ABSTRACTThe article entitled "Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting Opioid Analgesics: Considerations for Pain and Palliative Care Practice" that appears in this issue of the journal addresses the important new Food and Drug Administration (F...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of pain & palliative care pharmacotherapy Vol. 26; no. 2; pp. 134 - 135
Main Author:	Craig, David S.
Format:	Journal Article
Language:	English
Published:	England Informa Healthcare 22-06-2012 Taylor & Francis
Subjects:	Analgesics, Opioid - administration & dosage benefits Humans limitations opioid Opioid-Related Disorders - prevention & control Pain - drug therapy Palliative Care - methods REMS Risk Evaluation and Mitigation Strategy risks
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	ABSTRACTThe article entitled "Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting Opioid Analgesics: Considerations for Pain and Palliative Care Practice" that appears in this issue of the journal addresses the important new Food and Drug Administration (FDA) REMS program. This commentary expands on themes introduced by Dr. Gudin, projects future directions for REMS, and discusses possible benefits, limitations, and risks associated with the extended-release long-acting opioid REMS.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Commentary-1
ISSN:	1536-0288 1536-0539
DOI:	10.3109/15360288.2012.680011